{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:45:33Z","timestamp":1777506333925,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001655","name":"German Academic Exchange Service","doi-asserted-by":"publisher","award":["A\/11\/94299, 91540213"],"award-info":[{"award-number":["A\/11\/94299, 91540213"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00726-015-2131-x","type":"journal-article","created":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T17:14:01Z","timestamp":1449594841000},"page":"833-847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Radiopharmacological characterization of 64Cu-labeled \u03b1-MSH analogs for potential use in imaging of malignant melanoma"],"prefix":"10.1007","volume":"48","author":[{"given":"Feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Sihver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Jurischka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen","family":"Haase-Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Mosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Steinbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Carta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Bolzati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Calderan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00fcrgen","family":"Pietzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,7]]},"reference":[{"key":"2131_CR1","unstructured":"American Cancer Society (2015) Cancer Facts & Figures. http:\/\/www.cancer.org\/acs\/groups\/content\/@editorial\/documents\/document\/acspc-044552.pdf . Assessed 13 Jan 2015"},{"key":"2131_CR2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01457853","volume":"55","author":"H Ashton","year":"1977","unstructured":"Ashton H, Millman JE, Telford R, Thompson JW, Davies TF, Hall R, Shuster S, Thody AJ, Coy DH, Kastin AJ (1977) Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal man. Psychopharmacology 55:165\u2013172","journal-title":"Psychopharmacology"},{"key":"2131_CR3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/10799890701723528","volume":"27","author":"JP Bapst","year":"2007","unstructured":"Bapst JP, Froidevaux S, Calame M, Tanner H, Eberle AN (2007) Dimeric DOTA-alpha- melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity. J Recept Signal Transduct Res 27:383\u2013409","journal-title":"J Recept Signal Transduct Res"},{"key":"2131_CR4","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1021\/bc900007u","volume":"20","author":"JP Bapst","year":"2009","unstructured":"Bapst JP, Calame M, Tanner H, Eberle AN (2009) Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution. Bioconjug Chem 20:984\u2013993","journal-title":"Bioconjug Chem"},{"key":"2131_CR5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s002590050216","volume":"25","author":"TM Behr","year":"1998","unstructured":"Behr TM, Goldenberg DM, Becker W (1998) Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med 25:201\u20132011","journal-title":"Eur J Nucl Med"},{"issue":"Suppl 1","key":"2131_CR6","first-page":"182","volume":"16","author":"B Biondi","year":"2010","unstructured":"Biondi B, Bolzati C, Carta D, Salvarese N, Refosco F, Calderan A, Ruzza P (2010) The [Tc(N)PNP] metal fragment labeled peptide for MC1 receptors imaging: preliminary studies. J Peptide Sci 16(Suppl 1):182","journal-title":"J Peptide Sci"},{"key":"2131_CR7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0300-9629(84)90589-9","volume":"78","author":"AM Castrucci","year":"1984","unstructured":"Castrucci AM, Hadley ME, Sawyer TK, Hruby VJ (1984) Enzymological studies of melanotropins. Comp Biochem Physiol B 78:519\u2013524","journal-title":"Comp Biochem Physiol B"},{"key":"2131_CR8","first-page":"5649","volume":"60","author":"J Chen","year":"2000","unstructured":"Chen J, Cheng Z, Hoffman TJ, Jurisson SS, Quinn TP (2000) Melanoma-targeting properties of (99\u00a0m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues. Cancer Res 60:5649\u20135658","journal-title":"Cancer Res"},{"key":"2131_CR9","first-page":"1847","volume":"42","author":"J Chen","year":"2001","unstructured":"Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP (2001) Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties. J Nucl Med 42:1847\u20131855","journal-title":"J Nucl Med"},{"issue":"4 Suppl","key":"2131_CR10","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.10284","volume":"94","author":"JQ Chen","year":"2002","unstructured":"Chen JQ, Cheng Z, Miao YB, Jurisson SS, Quinn TP (2002) Alpha-melanocyte- stimulating hormone peptide analogs labeled with technetium-99\u00a0m and indium-111 for malignant melanoma targeting. Cancer 94(4 Suppl):1196\u20131201","journal-title":"Cancer"},{"key":"2131_CR11","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1021\/jm010408m","volume":"45","author":"Z Cheng","year":"2002","unstructured":"Cheng Z, Chen J, Miao Y, Owen NK, Quinn TP, Jurisson SS (2002) Modification of the structure of a metallopeptide: synthesis and biological evaluation of (111)In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues. J Med Chem 45:3048\u20133056","journal-title":"J Med Chem"},{"key":"2131_CR12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/0008-5472.CAN-03-0193","volume":"64","author":"Z Cheng","year":"2004","unstructured":"Cheng Z, Chen J, Quinn TP, Jurisson SS (2004a) Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma. Cancer Res 64:1411\u20131418","journal-title":"Cancer Res"},{"key":"2131_CR13","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1158\/0008-5472.CAN-03-0193","volume":"64","author":"Z Cheng","year":"2004","unstructured":"Cheng Z, Chen J, Quinn TP, Jurisson SS (2004b) Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma. Cancer Res 64:1411\u20131418","journal-title":"Cancer Res"},{"key":"2131_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/bc060306g","volume":"18","author":"Z Cheng","year":"2007","unstructured":"Cheng Z, Xiong ZM, Subbarayan M, Chen XY, Gambhir SS (2007a) Cu-64-labeled alpha-melanocyte-stimulating hormone analog for MicroPET imaging of melanocortin 1 receptor expression. Bioconjug Chem 18:765\u2013772","journal-title":"Bioconjug Chem"},{"key":"2131_CR15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2967\/jnumed.107.039602","volume":"48","author":"Z Cheng","year":"2007","unstructured":"Cheng Z, Zhang L, Graves E, Xiong Z, Dandekar M, Chen X, Gambhir SS (2007b) Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte- stimulating hormone analog. J Nucl Med 48:987\u2013994","journal-title":"J Nucl Med"},{"issue":"Pt 8","key":"2131_CR16","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1242\/jcs.109.8.2023","volume":"109","author":"J Chluba-de Tapia","year":"1996","unstructured":"Chluba-de Tapia J, Bagutti C, Cotti R, Eberle AN (1996) Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene. J Cell Sci 109(Pt 8):2023\u20132030","journal-title":"J Cell Sci"},{"key":"2131_CR17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1021\/bc300037w","volume":"23","author":"MS Cooper","year":"2012","unstructured":"Cooper MS, Ma MT, Sunassee K, Shaw KP, Williams JD, Paul RL, Donnelly PS, Blower PJ (2012) Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro\/in vivo stability. Bioconjug Chem 23:1029\u20131039. doi: 10.1021\/bc300037w","journal-title":"Bioconjug Chem"},{"key":"2131_CR18","doi-asserted-by":"crossref","unstructured":"Eberle AN (1988) 10. Secretion, Distribution and inactivation of MSH. In: Eberle AN (ed) The melanotropins. Chemistry, physiology and mechanisms of action, 1st edn. Karger, Basel, pp 173\u2013209","DOI":"10.1159\/000415281"},{"key":"2131_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10799899109066410","volume":"11","author":"AN Eberle","year":"1991","unstructured":"Eberle AN, Verin VJ, Solca F, Siegrist W, K\u00fcenlin C, Bagutti C, Stutz S, Girard J (1991) Biologically active monoiodinated alpha-MSH derivatives for receptor binding studies using human melanoma cells. J Recept Res 11:311\u2013312","journal-title":"J Recept Res"},{"key":"2131_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4419-6354-3_11","volume":"681","author":"AN Eberle","year":"2010","unstructured":"Eberle AN, Bapst JP, Calame M, Tanner H, Froidevaux S (2010) MSH radiopeptides for targeting melanoma metastases. Adv Exp Med Biol 681:133\u2013142. doi: 10.1007\/978-1-4419-6354-3_11","journal-title":"Adv Exp Med Biol"},{"key":"2131_CR21","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/s00259-011-2001-z","volume":"39","author":"M Fani","year":"2012","unstructured":"Fani M, Maecke HR (2012) Radiopharmaceutical development of radiolabelled peptides. Eur J Nucl Med Mol Imaging 39:S11\u2013S30. doi: 10.1007\/s00259-011-2001-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2131_CR22","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/mp400248f","volume":"10","author":"AM Flook","year":"2013","unstructured":"Flook AM, Yang J, Miao Y (2013) Evaluation of new Tc-99\u00a0m-labeled Arg-X-Asp-conjugated \u03b1-melanocyte stimulating hormone peptides for melanoma imaging. Mol Pharm 10:3417\u20133424. doi: 10.1021\/mp400248f","journal-title":"Mol Pharm"},{"key":"2131_CR23","first-page":"1699","volume":"43","author":"S Froidevaux","year":"2002","unstructured":"Froidevaux S, Calame-Christe M, Tanner H, Sumanovski L, Eberle AN (2002) A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis. J Nucl Med 43:1699\u20131706","journal-title":"J Nucl Med"},{"key":"2131_CR24","first-page":"116","volume":"45","author":"S Froidevaux","year":"2004","unstructured":"Froidevaux S, Calame-Christe M, Schuhmacher J, Tanner H, Saffrich R, Henze M, Eberle AN (2004) A gallium-labeled DOTA-alpha-melanocyte-stimulating hormone analog for PET Imaging of melanoma metastases. J Nucl Med 45:116\u2013123","journal-title":"J Nucl Med"},{"key":"2131_CR25","first-page":"887","volume":"46","author":"S Froidevaux","year":"2005","unstructured":"Froidevaux S, Calame-Christe M, Tanner H, Eberle AN (2005) Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake. J Nucl Med 46:887\u2013895","journal-title":"J Nucl Med"},{"key":"2131_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.jidsp.5640192","volume":"4","author":"Y Funasaka","year":"1999","unstructured":"Funasaka Y, Sato H, Chakraborty AK, Ohashi A, Chrousos GP, Ichihashi M (1999) Expression of proopiomelanocortin, corticotropin-releasing hormone (CRH), and CRH receptor in melanoma cells, nevus cells, and normal human melanocytes. J Investig Dermatol Symp Proc 4:105\u2013109","journal-title":"J Investig Dermatol Symp Proc"},{"key":"2131_CR27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.cbpa.2005.06.010","volume":"9","author":"S Fung","year":"2005","unstructured":"Fung S, Hruby VJ (2005) Design of cyclic and other templates for potent and selective peptide alpha-MSH analogues. Curr Opin Chem Biol 9:352\u2013358","journal-title":"Curr Opin Chem Biol"},{"key":"2131_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/1871520614666140825123150","volume":"15","author":"MF Garcia","year":"2014","unstructured":"Garcia MF, Zhang X, Gallazzi F, Fernandez M, Moreno M, Gambini JP, Porcal W, Cabral P, Quinn TP (2014) Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging. Anticancer Agents Med Chem 15:122\u2013130","journal-title":"Anticancer Agents Med Chem"},{"key":"2131_CR29","doi-asserted-by":"crossref","first-page":"12814","DOI":"10.1073\/pnas.95.22.12814","volume":"95","author":"MF Giblin","year":"1998","unstructured":"Giblin MF, Wang N, Hoffman TJ, Jurisson SS, Quinn TP (1998) Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proc Natl Acad Sci U S A 95:12814\u201312818","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2131_CR30","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1021\/mp300246j","volume":"9","author":"H Guo","year":"2012","unstructured":"Guo H, Miao Y (2012) Cu-64-labeled lactam bridge-cyclized \u03b1-MSH peptides for PET imaging of melanoma. Mol Pharm 9:2322\u20132330. doi: 10.1021\/mp300246j","journal-title":"Mol Pharm"},{"key":"2131_CR31","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1021\/bc9003475","volume":"20","author":"H Guo","year":"2009","unstructured":"Guo H, Yang J, Gallazzi F, Prossnitz ER, Sklar LA, Miao Y (2009a) Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide. Bioconjug Chem 20:2162\u20132168. doi: 10.1021\/bc9003475","journal-title":"Bioconjug Chem"},{"key":"2131_CR32","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/bc900428x","volume":"20","author":"H Guo","year":"2009","unstructured":"Guo H, Yang J, Shenoy N, Miao Y (2009b) Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging. Bioconjug Chem 20:2356\u20132363","journal-title":"Bioconjug Chem"},{"key":"2131_CR33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2967\/jnumed.109.071787","volume":"51","author":"H Guo","year":"2010","unstructured":"Guo H, Yang J, Gallazzi F, Miao Y (2010) Reduction of the ring size of radiolabeled lactam bridge-cyclized alpha-MSH peptide, resulting in enhanced melanoma uptake. J Nucl Med 51:418\u2013426","journal-title":"J Nucl Med"},{"key":"2131_CR34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3892\/ijo.2015.2832","volume":"46","author":"MH Kim","year":"2015","unstructured":"Kim MH, Park JA, Woo SK, Lee KC, An GI, Kim BS, Kim KI, Lee TS, Kim CW, Kim KM, Kang JH, Lee YJ (2015) Evaluation of a 64Cu-labeled 1,4,7-triazacyclononane, 1-glutaric acid-4,7 acetic acid (NODAGA)-galactose-bombesin analogue as a PET imaging probe in a gastrin-releasing peptide receptor-expressing prostate cancer xenograft model. Int J Oncol 46:1159\u20131168. doi: 10.3892\/ijo.2015.2832","journal-title":"Int J Oncol"},{"key":"2131_CR35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2005.02.021","volume":"512","author":"S Kopanchuk","year":"2005","unstructured":"Kopanchuk S, Veiksina S, Petrovska R, Mutule I, Szardenings M, Rinken A, Wikberg JE (2005) Co-operative regulation of ligand binding to melanocortin receptor subtypes: evidence for interacting binding sites. Eur J Pharmacol 512:85\u201395","journal-title":"Eur J Pharmacol"},{"key":"2131_CR36","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1021\/bc200197h","volume":"22","author":"L Lang","year":"2011","unstructured":"Lang L, Li W, Guo N, Ma Y, Zhu L, Kiesewetter DO, Shen B, Niu G, Chen X (2011) Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjug Chem 22:2415\u20132422. doi: 10.1021\/bc200197h","journal-title":"Bioconjug Chem"},{"key":"2131_CR37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/cbr.2011.1140","volume":"27","author":"JC Lim","year":"2012","unstructured":"Lim JC, Hong YD, Kim JJ, Choi SM, Baek HS, Choi SJ (2012) Synthesis and biological evaluation of a novel (177)Lu-DOTA-[Gly(3)-cyclized(Dap(4), (d)-Phe(7), Asp(10))-Arg(11)]\u03b1-MSH(3-13) analogue for melanocortin-1 receptor-positive tumor targeting. Cancer Biother Radiopharm 27:464\u2013472","journal-title":"Cancer Biother Radiopharm"},{"key":"2131_CR38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ajd.12121","volume":"55","author":"MJ Lin","year":"2014","unstructured":"Lin MJ, Mar V, McLean C, Wolfe R, Kelly JW (2014) Diagnostic accuracy of malignant melanoma according to subtype. Australas J Dermatol 55:35\u201342. doi: 10.1111\/ajd.12121","journal-title":"Australas J Dermatol"},{"key":"2131_CR39","doi-asserted-by":"crossref","first-page":"e87816","DOI":"10.1371\/journal.pone.0087816","volume":"9","author":"A Lindskog Jonsson","year":"2014","unstructured":"Lindskog Jonsson A, Granqvist A, Elvin J, Johansson ME, Haraldsson B, Nystr\u00f6m J (2014) Effects of melanocortin 1 receptor agonists in experimental nephropathies. PLoS ONE 9:e87816. doi: 10.1371\/journal.pone.0087816","journal-title":"PLoS ONE"},{"key":"2131_CR40","first-page":"1083","volume":"45","author":"B Loir","year":"1999","unstructured":"Loir B, P\u00e9rez S\u00e1nchez C, Ghanem G, Lozano JA, Garc\u00eda-Borr\u00f3n JC, Jim\u00e9nez- Cervantes G (1999) Expression of the MC1 receptor gene in normal and malignant human melanocytes. A semiquantitative RT-PCR study. Cell Mol Biol 45:1083\u20131092","journal-title":"Cell Mol Biol"},{"key":"2131_CR41","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1167\/iovs.06-0090","volume":"48","author":"MN L\u00f3pez","year":"2007","unstructured":"L\u00f3pez MN, Pereda C, Ram\u00edrez M, Mendoza-Naranjo A, Serrano A, Ferreira A, Poblete R, Kalergis AM, Kiessling R, Salazar-Onfray F (2007) Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy. Invest Ophthalmol Vis Sci 48:1219\u20131227","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2131_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00008390-199205000-00002","volume":"2","author":"J Lunec","year":"1992","unstructured":"Lunec J, Pieron C, Thody AJ (1992) MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma. Melanoma Res 2:5\u201312","journal-title":"Melanoma Res"},{"key":"2131_CR43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ki.1979.128","volume":"16","author":"T Maack","year":"1979","unstructured":"Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D (1979) Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16:251\u2013270","journal-title":"Kidney Int"},{"key":"2131_CR44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ijc.10640","volume":"101","author":"Y Miao","year":"2002","unstructured":"Miao Y, Owen NK, Whitener D, Gallazzi F, Hoffman TJ, Quinn TP (2002) In vivo evaluation of 188Re-labeled alpha-melanocyte stimulating hormone peptide analogs for melanoma therapy. Int J Cancer 101:480\u2013487","journal-title":"Int J Cancer"},{"key":"2131_CR45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/bc034069i","volume":"14","author":"Y Miao","year":"2003","unstructured":"Miao Y, Whitener D, Feng W, Owen NK, Chen J, Quinn TP (2003) Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues. Bioconjug Chem 14:1177\u20131184","journal-title":"Bioconjug Chem"},{"key":"2131_CR46","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/bc700317w","volume":"19","author":"Y Miao","year":"2008","unstructured":"Miao Y, Gallazzi F, Guo H, Quinn TP (2008) In-111-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide analogues for melanoma imaging. Bioconjug Chem 19:539\u2013547. doi: 10.1021\/bc700317w","journal-title":"Bioconjug Chem"},{"key":"2131_CR47","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/jm301647t","volume":"56","author":"M Morais","year":"2013","unstructured":"Morais M, Oliveira BL, Correia JD, Oliveira MC, Jim\u00e9nez MA, Santos I, Raposinho PD (2013) Influence of the bifunctional chelator on the pharmacokinetic properties of 99mTc(CO)3-labeled cyclic \u03b1-melanocyte stimulating hormone analog. J Med Chem 56:1961\u20131973. doi: 10.1021\/jm301647t","journal-title":"J Med Chem"},{"key":"2131_CR48","doi-asserted-by":"crossref","first-page":"R560","DOI":"10.1152\/ajpregu.00279.2005","volume":"290","author":"XP Ni","year":"2006","unstructured":"Ni XP, Bhargava A, Pearce D, Humphreys MH (2006) Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney. Am J Physiol Regul Integr Comp Physiol 290:R560\u2013R567","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2131_CR49","first-page":"863","volume":"1","author":"G Petrangolini","year":"2003","unstructured":"Petrangolini G, Pratesi G, De Cesare M, Supino R, Pisano C, Marcellini M, Giordano V, Laccabue D, Lanzi C, Zunino F (2003) Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts. Mol Cancer Res 1:863\u2013870","journal-title":"Mol Cancer Res"},{"key":"2131_CR50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00775-007-0338-3","volume":"13","author":"PD Raposinho","year":"2008","unstructured":"Raposinho PD, Xavier C, Correia JDG, Falcao S, Gomes P, Santos I (2008) Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[Tc-99m(CO)(3)](+): effect of cyclization on tumor-seeking properties. J Biol Inorgan Chem 13:449\u2013459. doi: 10.1007\/s00775-007-0338-3","journal-title":"J Biol Inorgan Chem"},{"key":"2131_CR51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.0022-202X.2004.23444.x","volume":"123","author":"A Ringholm","year":"2004","unstructured":"Ringholm A, Klovins J, Rudzish R, Phillips S, Rees JL, Schi\u00f6th HB (2004) Pharmacological characterization of loss of function mutations of the human melanocortin 1 receptor that are associated with red hair. J Invest Dermatol 123:917\u2013923","journal-title":"J Invest Dermatol"},{"key":"2131_CR52","first-page":"E47","volume":"245","author":"D Rudman","year":"1983","unstructured":"Rudman D, Hollins BM, Kutner MH, Moffitt SD, Lynn MJ (1983) Three types of alpha-melanocyte-stimulating hormone: bioactivities and half-lives. Am J Physiol 245:E47\u2013E54","journal-title":"Am J Physiol"},{"key":"2131_CR53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.bjc.6600441","volume":"87","author":"F Salazar-Onfray","year":"2002","unstructured":"Salazar-Onfray F, L\u00f3pez M, Lundqvist A, Aguirre A, Escobar A, Serrano A, Korenblit C, Petersson M, Chhajlani V, Larsson O, Kiessling R (2002) Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer 87:414\u2013422","journal-title":"Br J Cancer"},{"key":"2131_CR54","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1073\/pnas.77.10.5754","volume":"77","author":"TK Sawyer","year":"1980","unstructured":"Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB, Hadley ME (1980) 4-Norleucine, 7-d-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci U S A 77:5754\u20135758","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2131_CR55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0024-3205(96)00370-0","volume":"59","author":"HB Schi\u00f6th","year":"1996","unstructured":"Schi\u00f6th HB, Chhajlani V, Muceniece R, Klusa V, Wikberg JE (1996) Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Life Sci 59:797\u2013801","journal-title":"Life Sci"},{"key":"2131_CR56","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1124\/mol.54.1.154","volume":"54","author":"HB Schi\u00f6th","year":"1998","unstructured":"Schi\u00f6th HB, Yook P, Muceniece R, Wikberg JE, Szardenings M (1998) Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides. Mol Pharmacol 54:154\u2013161","journal-title":"Mol Pharmacol"},{"key":"2131_CR57","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1021\/ic101775q","volume":"50","author":"J Schlesinger","year":"2011","unstructured":"Schlesinger J, Rajander J, Ihalainen JA, Ramesh D, Eklund P, Fagerholm V, Nuutila P, Solin O (2011) Isomerism of [64Cu-NOTA-Bn]-labeled radiotracers: separation of two complex isomers and determination of their interconversion energy barrier using ion pair chromatography. Inorg Chem 50:4260\u20134271. doi: 10.1021\/ic101775q","journal-title":"Inorg Chem"},{"key":"2131_CR58","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymeth.2009.03.012","volume":"48","author":"M Schottelius","year":"2009","unstructured":"Schottelius M, Wester HJ (2009) Molecular imaging targeting peptide receptors. Methods 48:161\u2013177. doi: 10.1016\/j.ymeth.2009.03.012","journal-title":"Methods"},{"key":"2131_CR59","doi-asserted-by":"crossref","first-page":"11600","DOI":"10.3390\/molecules190811600","volume":"19","author":"Y Shao","year":"2014","unstructured":"Shao Y, Liang W, Kang F, Yang W, Ma X, Li G, Zong S, Chen K, Wang J (2014) 68Ga-labeled cyclic NGR peptide for microPET imaging of CD13 receptor expression. Molecules 19:11600\u201311612. doi: 10.3390\/molecules190811600","journal-title":"Molecules"},{"key":"2131_CR60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ki.2012.447","volume":"83","author":"J Si","year":"2013","unstructured":"Si J, Ge Y, Zhuang S, Wang LJ, Chen S, Gong R (2013) Adrenocorticotropic hormone ameliorates acute kidney injury by steroidogenic-dependent and -independent mechanisms. Kidney Int 83:635\u2013646. doi: 10.1038\/ki.2012.447","journal-title":"Kidney Int"},{"key":"2131_CR61","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/1043-2760(95)00017-C","volume":"6","author":"W Siegrist","year":"1995","unstructured":"Siegrist W, Eberle AN (1995) Melanocortins and their implication in melanoma. Trends Endocrinol Metab 6:115\u2013120","journal-title":"Trends Endocrinol Metab"},{"key":"2131_CR62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/10799898809048996","volume":"8","author":"W Siegrist","year":"1988","unstructured":"Siegrist W, Oestreicher M, Stutz S, Girard J, Eberle AN (1988) Radioreceptor assay for alpha-MSH using mouse B16 melanoma cells. J Recept Res 8:323\u2013343","journal-title":"J Recept Res"},{"key":"2131_CR63","first-page":"6352","volume":"49","author":"W Siegrist","year":"1989","unstructured":"Siegrist W, Solca F, Stutz S, Giuffre L, Carrel S, Girard J, Eberle AN (1989) Characterization of Receptors for Alpha-Melanocyte-Stimulating Hormone on Human-Melanoma Cells. Cancer Res 49:6352\u20136358","journal-title":"Cancer Res"},{"key":"2131_CR64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/bbrc.1996.0030","volume":"218","author":"W Siegrist","year":"1996","unstructured":"Siegrist W, Willard DH, Wilkison WO, Eberle AN (1996) Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors. Biochem Biophys Res Commun 218:171\u2013175","journal-title":"Biochem Biophys Res Commun"},{"key":"2131_CR65","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s00726-012-1409-5","volume":"43","author":"N Tandler","year":"2012","unstructured":"Tandler N, Mosch B, Pietzsch J (2012) Protein and non-protein biomarkers in melanoma: a critical update. Amino Acids 43:2203\u20132230. doi: 10.1007\/s00726-012-1409-5","journal-title":"Amino Acids"},{"key":"2131_CR66","first-page":"1237","volume":"50","author":"JB Tatro","year":"1990","unstructured":"Tatro JB, Entwistle ML, Lester BR, Reichlin S (1990) Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ. Cancer Res 50:1237\u20131242","journal-title":"Cancer Res"},{"key":"2131_CR67","doi-asserted-by":"crossref","first-page":"6695","DOI":"10.1016\/j.bmc.2010.07.061","volume":"18","author":"J Yang","year":"2010","unstructured":"Yang J, Guo H, Padilla RS, Berwick M, Miao Y (2010) Replacement of the Lys linker with an Arg linker resulting in improved melanoma uptake and reduced renal uptake of Tc-99\u00a0m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide. Bioorg Med Chem 18:6695\u20136700","journal-title":"Bioorg Med Chem"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-2131-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-015-2131-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-2131-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T14:08:27Z","timestamp":1653746907000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-015-2131-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,7]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2131"],"URL":"https:\/\/doi.org\/10.1007\/s00726-015-2131-x","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,7]]}}}